Medicine and Dentistry
Malignant Neoplasm
84%
Infection
45%
Hematologic Malignancy
30%
Blood Culture
29%
Bloodstream Infection
24%
Cytomegalovirus
24%
Transplantation
23%
Central Venous Catheter
22%
Fungemia
18%
Tertiary Care
18%
Hematopoietic Stem Cell Transplantation
13%
Catheter Infection
13%
Mycobacterium Avium-Intracellulare Infection
12%
Candidemia
12%
Viral Respiratory Tract Infection
12%
Immunocompromised Patient
10%
Mortality Rate
10%
Invasive Aspergillosis
10%
Breast Cancer
9%
Cytomegalovirus Infection
9%
Diagnosis
9%
Neutropenia
9%
Patient with Leukemia
8%
Prospective Study
8%
Aspergillus
8%
Virus Infection
8%
Solid Malignant Neoplasm
8%
Hematopoietic Cell
8%
Systemic Mycosis
8%
Case-Control Study
8%
Nocardia
8%
Infection Complication
8%
BK Virus
8%
Echinocandin
7%
Allogeneic Hematopoietic Stem Cell Transplantation
7%
Respiratory Failure
7%
Antibiotics
7%
Mixed Infection
6%
Leukemia
6%
Pyrrole
6%
Gram-Negative Bacteria
6%
Mycobacterium avium
6%
Mycobacterium kansasii
6%
Cohort Effect
6%
Legionella
6%
Infectious Disease
5%
Pyrrole Derivative
5%
Cancer
5%
Prevalence
5%
Human respiratory syncytial virus
5%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Infection
59%
Bloodstream Infection
41%
Hematologic Malignancy
29%
Leukemia
19%
Cytomegalovirus
19%
Ganciclovir
18%
Human respiratory syncytial virus
16%
Respiratory Syncytial Virus Infection
14%
Diseases
14%
Cytomegalovirus Infection
14%
Fluconazole
13%
Mortality Rate
13%
Candidemia
13%
Breast Cancer
12%
Escherichia coli
12%
Caspofungin
11%
Respiratory Failure
11%
Candida
11%
Pyrrole
10%
Mould
10%
Ribavirin
9%
Invasive Aspergillosis
9%
Antifungal Agent
8%
Legionella
8%
Surgical Infection
8%
Mucormycosis
8%
Fungemia
8%
Candida albicans
8%
Candidiasis
8%
Penicillinase
8%
Antiviral Therapy
8%
Viral Respiratory Tract Infection
8%
Echinocandin
7%
Monotherapy
7%
Neutropenia
6%
Mucorales
5%
Chemotherapy
5%
Aspergillus
5%
Prevalence
5%
Pseudomonas aeruginosa
5%
Foscarnet
5%
Daptomycin
5%
Linezolid
5%
Combination Therapy
5%
Antibiotics
5%
Case-Control Study
5%
Keyphrases
Cancer Patients
46%
Bacteremia
35%
In Cancer
31%
Hematological Malignancies
30%
Patients with Cancer
25%
Tertiary Care
22%
Cancer Center
22%
Azoles
18%
Blood Culture
17%
Central Venous Catheter
17%
Leukemia
15%
Invasive Pulmonary Aspergillosis
15%
Catheter-related
13%
Cytomegalovirus Pneumonia
12%
Respiratory Viral Infection
12%
Fluconazole
11%
Fungemia
10%
Clinical Outcomes
10%
Lymphoma
10%
Gram-negative Bacilli
10%
Candida Glabrata
10%
Transplant Recipients
10%
Epstein-Barr Virus
9%
Retrospective Review
9%
Marrow Transplantation
8%
Chronic Lymphocytic Leukemia
8%
Quantitative PCR
8%
Respiratory Syncytial Virus
8%
Bloodstream Infection
8%
In Vitro Susceptibility
8%
Invasive Aspergillosis
8%
Vancomycin-resistant Enterococci
8%
Candidemia
8%
Cytomegalovirus Infection
8%
Valganciclovir Prophylaxis
8%
Cytomegalovirus
7%
Echinocandins
7%
MD Anderson Cancer Center
7%
Neutropenia
7%
MicroRNA
7%
Caspofungin
7%
Leukemia Patients
7%
Minimum Inhibitory Concentration
6%
Initial Treatment
6%
Catheter-related Bloodstream Infection (CRBSI)
6%
Pseudomonas Aeruginosa (P. aeruginosa)
6%
Escherichia Coli Bacteremia
6%
Piperacillin-tazobactam
6%
Aspergillosis
6%
Hematological Cancer
5%
